Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad372 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Hannah Gilliam-Vigh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Gastrointestinal Hormones. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Gentofte Hospital, University of Copenhagen, Overlæge Johan Boserup og Lise Boserups Legat.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
The hormone secretin (SCT) is released from intestinal S cells and acts via the SCT receptor (SCTR). Circulating SCT levels increase after Roux-en-Y gastric bypass surgery and have been associated with massive weight loss and high remission rates of type 2 diabetes (T2D) linked to these operations. Exogenous SCT was recently shown to reduce ad libitum food intake in healthy volunteers.
Objective
To understand SCT biology and its potential role in T2D pathophysiology, we examined the intestinal mucosal expression profile of SCT and SCTR and evaluated the density of S cells along the intestinal tract of individuals with T2D and healthy controls.
Methods
Using immunohistochemistry and messenger RNA (mRNA) sequencing, we analyzed intestinal mucosa biopsies sampled along the small intestine at 30-cm intervals and from 7 well-defined anatomical sites along the large intestine (during 2 sessions of double-balloon enteroscopy) in 12 individuals with T2D and 12 healthy controls.
Results
Both groups exhibited a progressive and similar decrease in SCT and SCTR mRNA expression and S-cell density along the small intestine, with reductions of 14, 100, and 50 times, respectively, in the ileum compared to the duodenum (used as reference). Negligible amounts of SCTR and SCT mRNA, as well as low S-cell density, were found in the large intestine. No significant differences were observed between the groups.
Conclusion
SCT and SCTR mRNA expression and S-cell density were abundant in the duodenum and decreased along the small intestine. Very low SCT and SCTR mRNA levels and S-cell numbers were observed in the large intestine, without aberrations in individuals with T2D compared to healthy controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, 2900 Hellerup, Denmark.
- Section of Biostatistics, Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, 1353 Copenhagen K, Denmark.
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.
- Clinical Research, Steno Diabetes Center Copenhagen, 2730 Herlev, Denmark.
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen N, Denmark.
ORCID-Profile: Hannah Gilliam-Vigh, Tina Jorsal, Sophie W Nielsen, Julie L Forman, Jens Pedersen, Steen S Poulsen, Tina Vilsbøll, Filip K Knop
Förderung
- Gentofte Hospital
- University of Copenhagen
- Overlæge Johan Boserup og Lise Boserups Legat
- Novo Nordisk Foundation
Zitieren
APA
Gilliam-Vigh, H., Jorsal, T., Nielsen, S. W., Forman, J. L., Pedersen, J., Poulsen, S. S., Vilsbøll, T., & Knop, F. K. (2023). Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad372
Vancouver
Gilliam-Vigh H, Jorsal T, Nielsen SW, Forman JL, Pedersen J, Poulsen SS, et al. Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad372
BibTeX
@article{GilliamVigh2023,
author = {Gilliam-Vigh, Hannah and Jorsal, Tina and Nielsen, Sophie W and Forman, Julie L and Pedersen, Jens and Poulsen, Steen S and Vilsbøll, Tina and Knop, Filip K},
title = {Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad372}
}
EUVIMED